Khedhiri Marwa

Dr. Khedhiri Marwa

Institut Pasteur de Tunis, Tunis, Tunisia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2022 in Viruses
Verified
Journal Article
Open access
PDF file
Anissa ChouikhaAnissa Chouikha
Anissa Chouikha
WFWasfi Fares
Wasfi Fares
ALAsma LAMARI
Asma LAMARI
SHSondes Haddad-Boubaker
Sondes Haddad-Boubaker
ZBZeineb Belaiba
Zeineb Belaiba
HTHenda Triki
Henda Triki
Documenting the circulation dynamics of SARS-CoV-2 variants in different regions of the world is crucial for monitoring virus transmission worldwide and contributing to global efforts towards combating the pandemic. Tunisia has experienced several waves of COVID-19 with a significant number of infections and deaths. The present study provides genetic information on the different lineages of SARS-CoV-2 that circulated in Tunisia over 17 months. Lineages were assigned for 1359 samples using whole-genome sequencing, partial S gene sequencing and variant-specific real-time RT-PCR tests. Forty-eight different lineages of SARS-CoV-2 were identified, including variants of concern (VOCs), variants of interest (VOIs) and variants under monitoring (VUMs), particularly Alpha, Beta, Delta, A.27, Zeta and Eta. The first wave, limited to imported and import-related cases, was characterized by a small number of positive samples and lineages. During the second wave, a large number of lineages were detected; the third wave was marked by the predominance of the Alpha VOC, and the fourth wave was characterized by the predominance of the Delta VOC. This study adds new genomic data to the global context of COVID-19, particularly from the North African region, and highlights the importance of the timely molecular characterization of circulating strains.

28 March 2022 in Virology Journal
Verified
Journal Article
Open access
PDF file
MGmariem gdoura
mariem gdoura
IAImen Abouda
Imen Abouda
MMMehdi Mrad
Mehdi Mrad
IDImen Ben Dhifallah
Imen Ben Dhifallah
ZBZeineb Belaiba
Zeineb Belaiba
HTHenda Triki
Henda Triki
Introduction: RT-PCR testing on nasopharyngeal swabs is a key component in the COVID-19 fighting, provided to use sensitive and specific SARS-CoV2 genome targets. In this study, we aimed to evaluate and to compare 4 widely used WHO approved RT-PCR protocols on real clinical specimens, to decrypt the reasons of the diverging results and to propose recommendations for the choice of the genome targets. Methods: 260 nasopharyngeal samples were randomly selected among the samples tested between Week-16, 2020 and week-16 2021, in the Institut Pasteur de Tunis, Tunisia, one of the referent laboratories of COVID-19 in Tunisia. All samples were tested by Charité, Berlin protocol (singleplex envelop (E) and singleplex RNA-dependent RNA polymerase (RdRp)), Hong Kong Universiy, China protocol (singleplex nucleoprotein (N) and singleplex Open reading frame Orf1b), commercial test DAAN Gene® (using the CDC China protocol), (triplex N, Orf1ab with internal control) and Institut Pasteur Paris protocol (IPP) (triplex IP2(nsp9) and IP4 (nsp12) with internal control). For IPP, a selection from samples positive by IP2 but negative with IP4 was re-tested by exactly the same protocol but this time in singleplex. New results were described and analyzed. Results: In vitro analysis showed discordant results in 29.2% of cases (76 out of 260). The most discordant protocol is DAAN Gene® due to the false positive late signals with N target. Discordant results between the two protocol’s targets are more frequent when viral load are low (high Ct values). Our results demonstrated that the multiplexing has worsened the sensitivity of the IP4 target. Conclusion: We provide concise recommendations for the choice of the genome targets, the interpretation of the results and the alarm signals which makes suspect a gene mutation.

19 October 2019 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
DIDhifallah Ines
Dhifallah Ines
Khedhiri MarwaKhedhiri Marwa
Khedhiri Marwa
Anissa ChouikhaAnissa Chouikha
Anissa Chouikha
GKGhassen Kharroubi
Ghassen Kharroubi
WHWalid Hammami
Walid Hammami
OBOlfa Bahri
Olfa Bahri

22 December 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
WFWasfi Fares
Wasfi Fares
KGKais Ghedira
Kais Ghedira
MGMariem Gdoura
Mariem Gdoura
Anissa ChouikhaAnissa Chouikha
Anissa Chouikha
SHSondes Haddad-Boubaker
Sondes Haddad-Boubaker
HTHenda Triki
Henda Triki
The method of choice for SARS-CoV-2 variant detection is whole-genome sequencing using next-generation sequencing (NGS) technologies. Resources for this technology remain limited in many low- and middle-income countries, where it is not possible to perform whole-genome sequencing for representative numbers of SARS-CoV-2-positive cases.

10 June 2019 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
JBJihene Bettaieb
Jihene Bettaieb
Anissa ChouikhaAnissa Chouikha
Anissa Chouikha
Khedhiri MarwaKhedhiri Marwa
Khedhiri Marwa
GKGhassen Kharroubi
Ghassen Kharroubi
MBMalek Badreddine
Malek Badreddine
HTHenda Triki
Henda Triki

7 December 2023 in Journal of Clinical Virology
Verified
Journal Article
Closed access
Khedhiri MarwaKhedhiri Marwa
Khedhiri Marwa
MCMelek Chaouch
Melek Chaouch
KAKaouther Ayouni
Kaouther Ayouni
ACAnissa Chouikha
Anissa Chouikha
MGMariem Gdoura
Mariem Gdoura
HTHenda Triki
Henda Triki